|
|
All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.
The FDA recognizes 118 routes of administration.
Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.
It is difficult to obtain enough calcium without consuming milk or other dairy foods.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.